Search
for
Sort by
Research 421–450 of 1000+
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Retinoids in scarless skin regeneration: from molecular mechanisms to therapeutic strategies
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Combined Ultrasound and Microneedle for Enhanced Transdermal Delivery: Synergistic Mechanisms and Therapeutic Advances
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Answer of Regenerative Therapy Not Hair Treatment Patients with Androgenetic Alopecia Approved for Hairmetrix® Technology - Case Report
- Androgenetic alopecia; drug safety and therapeutic strategies
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Review of Human Hair Follicle Biology: Dynamics of Niches and Stem Cell Regulation for Possible Therapeutic Hair Stimulation for Plastic Surgeons
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Systematic review of platelet‐rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability
- Interferon in the treatment of cutaneous T-cell lymphoma
- Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy
- Gender-Affirming Hormone Therapy for Transgender Men
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Nanofibers: An Effective Biomedical Tool for Burn Management
- Acne and acneiform eruptions
- Selected topics in pediatric hair loss
- Macrophages as central mediators of sympathetic neuro-immune interplay in autoimmunity
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Application of Platelet-Rich Plasma as a Stem Cell Treatment - anAttempt to Clarify a Common Public Misconception
- Alopecia: managing the basics
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?